Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), announced new data from the ongoing Phase 1 dose escalation study of AG-221 as a single agent in patients with IDH2-mutant positive advanced hematologic malignancies. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) belongs to Healthcare sector. Its net profit margin is -82.60% and weekly performance is 11.46%. On last trading day company shares ended up $107.30. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) distance from 50-day simple moving average (SMA50) is 35.09%.

AES Corp (NYSE:AES) has been given a “BB-” credit rating by analysts at Morningstar. The firm’s “BB-” rating suggests that the company is an above-average default risk. They also gave their stock a three star rating. The AES Corporation (NYSE:AES) shares fell -0.58% in last trading session and ended the day at $13.60. AES Gross Margin is 18.00% and its return on assets is 0.90%. The AES Corporation (NYSE:AES) quarterly performance is -7.42%.

On Nov. 24, As Le Reve – The Dream, the aquatic and aerial show at Wynn Las Vegas, operated by international resort developer Wynn Resorts Ltd. (NASDAQ:WYNN), approaches its 10-year milestone in 2015, the production has introduced a unique installment that incorporates spectacular water, fire and projection technologies. On 08 December, Wynn Resorts Ltd. (NASDAQ:WYNN) shares fell -3.85% and was closed at $157.59. WYNN EPS growth in last 5 year was 30.10%. Wynn Resorts Ltd. (NASDAQ:WYNN) year to date (YTD) performance is -16.19%.

Pioneer Energy Services Corp (NYSE:PES) CEO Stacy Locke acquired 15,000 shares of the company’s stock on the open market in a transaction dated Monday, December 8th. The shares were purchased at an average cost of $5.22 per share, for a total transaction of $78,300.00. Pioneer Energy Services Corp. (NYSE:PES) ended the last trading day at $5.08. Company weekly volatility is calculated as 8.07% and price to cash ratio as 12.28. Pioneer Energy Services Corp. (NYSE:PES) showed a weekly performance of -12.86%.

NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY), said it has signed an exclusive distribution agreement with Egypt-based Biopharm Group for NovaBay’s NeutroPhase Skin and Wound Cleanser. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) belongs to Healthcare sector. Its weekly performance is 0.81%. On last trading day company shares ended up $0.68. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) distance from 50-day simple moving average (SMA50) is -9.42%.